SUBSEQUENT EVENTS (Additional Information) (Details) - USD ($) $ in Thousands			3 Months Ended	9 Months Ended
	Jul. 28, 2025	Jul. 16, 2025	Sep. 30, 2025	Sep. 30, 2025	Jun. 30, 2025	Dec. 31, 2024
Subsequent Event [Line Items]
Contingent consideration					$ 47,400	$ 47,400
LGMD FDA Clinical Hold [Member]
Subsequent Event [Line Items]
Contingent consideration					47,400
Myonexus Therapeutics, Inc. [Member] | LGMD FDA Clinical Hold [Member]
Subsequent Event [Line Items]
Contingent consideration					$ 47,100
Subsequent Event [Member]
Subsequent Event [Line Items]
Reduction in force percentage of companies workforce		36.00%
Subsequent Event [Member] | Arrowhead Agreement [Member]
Subsequent Event [Line Items]
Milestone payment	$ 100,000
Subsequent Event [Member] | Maximum [Member]
Subsequent Event [Line Items]
Restructuring Charges				$ 37,000
Subsequent Event [Member] | Minimum [Member]
Subsequent Event [Line Items]
Restructuring Charges			$ 32,000